BMJ 1994;308:871-872 (2 April)

Editorials

Antibiotics in chronic obstructive pulmonary disease

Patients with chronic obstructive pulmonary disease frequently develop respiratory infections. Occasionally the increased sputum volume and purulence fail to resolve after a course of an appropriate antibiotic, and hospital admission is often required. If the patient remains unwell with breathlessness and wheeze, continuing respiratory infection is presumed. Patients often receive repeated courses of antibiotics, which disturb the oropharyngeal flora and facilitate colonisation or invasion of the lung by different organisms or antibiotic resistant strains of the original organism.

In up to 40% of patients, however, sputum cultures show no growth.1 Even when an organism is isolated from sputum its pathogenic importance may be uncertain, and the clinical response to an appropriate antibiotic is often disappointing.2. Sometimes more than one type of organism is found, and the importance of each is difficult to determine. Doctors often have to choose between empirical antibiotic treatment and further attempts to make a microbiological . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Fluoroquinolones in chronic obstructive pulmonary disease
A Colville, M Knowles, D Large, J George, and P Mustchin
BMJ 1994 308: 1437. [Extract] [Full Text]

This article has been cited by other articles:

  • Saint, S., Bent, S., Vittinghoff, E., Grady, D. (1995). Antibiotics in Chronic Obstructive Pulmonary Disease Exacerbations: A Meta-analysis. JAMA 273: 957-960 [Abstract]  
  • Colville, A, Knowles, M, Large, D, George, J, Mustchin, P (1994). Fluoroquinolones in chronic obstructive pulmonary disease. BMJ 308: 1437-1437 [Full text]  
Access jobs at BMJ Careers
Whats new online at Student BMJ